We demonstrate the substantial antitumor effects of these iNK cells against solid tumors, conduct a deep characterization of their phenotypic and transcriptional states, and report how the interplay between tumor cells and MSLN.CAR-IL-15 iNK cells affects both populations during therapy. Here, IL15 is linked to neoplasm.